RSC Med. Chem., 2023, Accepted Manuscript
DOI: 10.1039/D3MD00306J, Research ArticleXiangyi Jiang, Jing Li, Antonio Viayna, F. Javier Luque, Molly Woodson, Lanlan Jing, Shenghua Gao, Fabao Zhao, Minghui Xie, karoly Toth, John Tavis, Ann. E Tollefson, Xinyong Liu, Peng Zhan
The SARS-CoV-2 3-chymotrypsin-like protease (3CLpro) is considered an attractive target for the development of anti-COVID-19 agents due to its vital function. The N-substituted isatin derivatives L-26 is a potential SARS-CoV-2…
The content of this RSS Feed (c) The Royal Society of Chemistry
Identification of Novel 1,2,3-triazole Isatin Derivatives as Potent SARS-CoV-2 3CLpro Inhibitors via Click-chemistry-based Rapid Screening
